Last reviewed · How we verify

NCT04012528: RAAC

ERAS and Pediatric Scoliosis Surgery

Status unknown Last updated 29 December 2020
What this trial tests

trial testing ERAS program in Scoliosis in 150 participants. Status unknown.

Timeline
1 January 2018
Primary endpoint
1 November 2020
30 November 2021

Quick facts

Lead sponsorUniversity Hospital, Montpellier
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment150
Start date1 January 2018
Primary completion1 November 2020
Estimated completion30 November 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

Under 18, any sex, with Scoliosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the outcomes after scoliosis surgery before and after ERAS (enhanced recovery after surgery) program inplementation in children and teenager.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ERAS program

Trials testing the same drug.

Other recruiting trials for Scoliosis

Currently open trials in the same condition.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04012528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing